Molecular Remission After Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Consolidation Therapy Following Double Autologous Transplantation for Multiple Myeloma: Results of a Qualitative and Quantitative Analysis

被引：0
|
作者：
Terragna, Carolina [1 ]
Zamagni, Elena [1 ]
Petrucci, Maria Teresa [2 ]
Durante, Sandra [1 ]
Patriarca, Francesca [3 ]
Narni, Franco [4 ]
Crippa, Claudia [5 ]
Gorgone, Ausilia [6 ]
Caravita, Tommaso [2 ]
Perrone, Giulia [1 ]
Nozzoli, Chiara [7 ]
Masini, Luciano [8 ]
Callea, Vincenzo [9 ]
Attolico, Immacolata [10 ]
Cellini, Claudia
Bringhen, Sara [11 ]
Ledda, Antonio [12 ]
Montefusco, Vittorio [13 ]
Martello, Marina [1 ]
Martinelli, Giovanni [1 ]
Baccarani, Michele [1 ]
Cavo, Michele [1 ]
机构：
[1] Univ Bologna, Sch Med, Seragnoli Inst Hematol, Bologna, Italy
[2] GIMEMA Italian Myeloma Network, Rome, Italy
[3] GIMEMA Italian Myeloma Network, Udine, Italy
[4] GIMEMA Italian Myeloma Network, Modena, Italy
[5] GIMEMA Italian Myeloma Network, Brescia, Italy
[6] GIMEMA Italian Myeloma Network, Catania, Italy
[7] GIMEMA Italian Myeloma Network, Florence, Italy
[8] GIMEMA Italian Myeloma Network, Reggio Emilia, Italy
[9] GIMEMA Italian Myeloma Network, Reggio Di Calabria, Italy
[10] GIMEMA Italian Myeloma Network, Potenza, Italy
[11] GIMEMA Italian Myeloma Network, Turin, Italy
[12] GIMEMA Italian Myeloma Network, Cagliari, Italy
[13] GIMEMA Italian Myeloma Network, Milan, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [1] Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Induction and Consolidation Therapy Before and After Double Autologous Transplantation In Newly Diagnosed Multiple Myeloma: Results From a Randomized Phase 3 Study
    Cavo, Michele
    Perrone, Giulia
    Buttignol, Silvia
    Calabrese, Elisabetta
    Galli, Monica
    Bringhen, Sara
    Spadano, Tonino
    Baldini, Luca
    Caravita, Tommaso
    Nozzoli, Chiara
    Brioli, Annamaria
    Masini, Luciano
    Furlan, Anna
    Pantani, Lucia
    Derudas, Daniele
    Ballanti, Stelvio
    Pisani, Francesco
    De Stefano, Valerio
    Catania, Gioacchino
    Castagna, Luca
    Ferrara, Felicetto
    Callea, Vincenzo
    Musto, Pellegrino
    Zamagni, Elena
    Baccarani, Michele
    [J]. BLOOD, 2010, 116 (21) : 25 - 25
  • [2] Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
    Cavo, Michele
    Pantani, Lucia
    Petrucci, Maria Teresa
    Patriarca, Francesca
    Zamagni, Elena
    Donnarumma, Daniela
    Crippa, Claudia
    Boccadoro, Mario
    Perrone, Giulia
    Falcone, Antonietta
    Nozzoli, Chiara
    Zambello, Renato
    Masini, Luciano
    Furlan, Anna
    Brioli, Annamaria
    Derudas, Daniele
    Ballanti, Stelvio
    Dessanti, Maria Laura
    De Stefano, Valerio
    Carella, Angelo Michele
    Marcatti, Magda
    Nozza, Andrea
    Ferrara, Felicetto
    Callea, Vincenzo
    Califano, Catello
    Pezzi, Annalisa
    Baraldi, Anna
    Grasso, Mariella
    Musto, Pellegrino
    Palumbo, Antonio
    [J]. BLOOD, 2012, 120 (01) : 9 - 19
  • [3] Bortezomib (Velcade)-thalidomide-dexamethasone is superior to thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation
    Garderet, L.
    Iacobelli, S.
    Moreau, P.
    Dib, M.
    Caillot, D.
    Niederwieser, D.
    Masszi, T.
    Fontan, J.
    Michallet, M.
    Gratwohl, A.
    Milone, G.
    Doyen, C.
    Pegourie, B.
    Hajek, R.
    Casassus, P.
    Kolb, B.
    Chaleteix, C.
    Hertenstein, B.
    Onida, F.
    Ludwig, H.
    Vekemans, M. C.
    Ketterer, N.
    Daguenel, A.
    Koenecke, C.
    Gorin, N. -C.
    Harousseau, J. -L.
    de Witte, T.
    Morris, C.
    Gahrton, G.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S3 - S3
  • [4] Bortezomib(Velcade®)-thalidomide-dexamethasone versus thalidomide-dexamethasone to treat multiple myeloma patients progressing or relapsing after autologous transplantation: the MMVAR trial
    Garderet, L.
    Iacobelli, S.
    Moreau, P.
    Onida, F.
    Koenecke, C.
    Scheid, C.
    Doyen, C.
    Bouko, Y.
    Ketterer, N.
    Masszi, T.
    Crawley, C.
    Hajek, R.
    Linkesch, W.
    Ludwig, H.
    Harousseau, J. L.
    Michallet, M.
    de Witte, T.
    Niederwieser, D.
    Gahrton, G.
    Morris, T. C. M.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S33 - S33
  • [5] Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy
    Alexanian, R
    Weber, D
    Giralt, S
    Delasalle, K
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (07) : 1116 - 1119
  • [6] Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation.
    Garderet, Laurent
    Iacobelli, Simona
    Moreau, Philippe
    Dib, Mamoun
    Caillot, Denis
    Niederwieser, Dietger W.
    Masszi, Tamas
    Fontan, Jean
    Michallet, Mauricette
    Gratwohl, Alois
    Milone, Giuseppe
    Doyen, Chantal
    Pegourie, Brigitte
    Hajek, Roman
    Casassus, Philippe
    Kolb, Brigitte
    Chaleteix, Carine
    Hertenstein, Bernd
    Onida, Francesco
    Ludwig, Heinz
    Vekemans, Marie Christiane
    Ketterer, Nicolas
    Daguenel, Anne
    Gorin, Norbert C.
    Harousseau, Jean Luc
    de Witte, Theo
    Morris, Curly
    Gahrton, Gosta
    [J]. BLOOD, 2010, 116 (21) : 1254 - 1254
  • [7] Impact of consolidation with bortezomib, thalidomide and dexamethasone on residual multiple myeloma cells after autologous transplantation assessed by qualitative and quantitative PCR
    Ladetto, M.
    Astolfi, M.
    Santo, L.
    Avonto, I.
    Cavallo, F.
    Pagliano, G.
    Pregno, P.
    Grasso, M.
    Liberati, A. M.
    Caravita, T.
    Pisani, F.
    Guglielmelli, T.
    Genuardi, E.
    Crivelli, R.
    Cristiano, C.
    Drandi, D.
    Boccadoro, M.
    Palumbo, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 329 - 329
  • [8] Bortezomib-thalidomide-dexamethasone versus bortezomib-cyclophosphamide-dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma
    Moreau, Philippe
    Mary, Jean-Yves
    Attal, Michel
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (04) : 605 - 606
  • [9] Persistent Improvement In Clinical Outcomes With Bortezomib-Thalidomide-Dexamethasone Vs Thalidomide-Dexamethasone Incorporated Into Double Autologous Transplantation For Multiple Myeloma: An Updated Analysis Of Phase 3 Gimema-MMY-3006 Study
    Cavo, Michele
    Galli, Monica
    Pezzi, Annalisa
    Di Raimondo, Francesco
    Crippa, Claudia
    Offidani, Massimo
    Tacchetti, Paola
    Montefusco, Vittorio
    Narni, Franco
    Spadano, Antonio
    Pescosta, Norbert
    Zamagni, Elena
    Gamberi, Barbara
    Caravita, Tommaso
    Falcone, Antonietta Pia
    Nozzoli, Chiara
    Zambello, Renato
    Furlan, Anna
    Brioli, Annamaria
    Boccadoro, Mario
    [J]. BLOOD, 2013, 122 (21)
  • [10] A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD
    Cavo, Michele
    Tacchetti, Paola
    Patriarca, Francesca
    Petrucci, Maria Teresa
    Pantani, Lucia
    Galli, Monica
    Di Raimondo, Francesco
    Crippa, Claudia
    Bringhen, Sara
    Offidani, Massimo
    Narni, Franco
    Montefusco, Vittorio
    Zamagni, Elena
    Spadano, Tonino
    Pescosta, Norbert
    Baldini, Luca
    Cellini, Claudia
    Caravita, Tommaso
    Ledda, Antonio
    Falcone, Antonietta
    Tosi, Patrizia
    Nozzoli, Chiara
    Zambello, Renato
    Masini, Luciano
    Agostini, Paola
    Fiacchini, Mauro
    Baccarani, Michele
    [J]. BLOOD, 2009, 114 (22) : 148 - 149
12345